These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 9135075

  • 1. p53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy.
    Pirollo KF, Hao Z, Rait A, Jang YJ, Fee WE, Ryan P, Chiang Y, Chang EH.
    Oncogene; 1997 Apr 10; 14(14):1735-46. PubMed ID: 9135075
    [Abstract] [Full Text] [Related]

  • 2. [Recombinant adenovirus-p53 gene therapy combined with radiotherapy for head and neck squamous-cell carcinoma].
    Zhang SW, Xiao SW, Liu CQ, Sun Y, Su X, Li DM, Xu G, Zhu GY, Xu B.
    Zhonghua Zhong Liu Za Zhi; 2005 Jul 10; 27(7):426-8. PubMed ID: 16188130
    [Abstract] [Full Text] [Related]

  • 3. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma.
    Clayman GL, el-Naggar AK, Roth JA, Zhang WW, Goepfert H, Taylor DL, Liu TJ.
    Cancer Res; 1995 Jan 01; 55(1):1-6. PubMed ID: 7805018
    [Abstract] [Full Text] [Related]

  • 4. Combination of mutated herpes simplex virus type 1 (G207 virus) with radiation for the treatment of squamous cell carcinoma of the head and neck.
    Kim SH, Wong RJ, Kooby DA, Carew JF, Adusumilli PS, Patel SG, Shah JP, Fong Y.
    Eur J Cancer; 2005 Jan 01; 41(2):313-22. PubMed ID: 15661558
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
    Masunaga S, Uto Y, Nagasawa H, Hori H, Nagata K, Suzuki M, Kinashi Y, Ono K.
    Anticancer Res; 2006 Jan 01; 26(2A):1261-70. PubMed ID: 16619533
    [Abstract] [Full Text] [Related]

  • 7. Therapy of head and neck squamous cell carcinoma with an oncolytic adenovirus expressing HSV-tk.
    Morris JC, Wildner O.
    Mol Ther; 2000 Jan 01; 1(1):56-62. PubMed ID: 10933912
    [Abstract] [Full Text] [Related]

  • 8. Effects of p53 gene therapy in radiotherapy or thermotherapy of human head and neck squamous cell carcinoma cell lines.
    Higuchi Y, Asaumi J, Murakami J, Matsuzaki H, Wakasa T, Inoue T, Shigehara H, Konouchi H, Hisatomi M, Kawasaki S, Hiraki Y, Kishi K.
    Oncol Rep; 2003 Jan 01; 10(3):671-7. PubMed ID: 12684642
    [Abstract] [Full Text] [Related]

  • 9. Radiosensitization of squamous cell carcinoma by the alkylphospholipid perifosine in cell culture and xenografts.
    Vink SR, Lagerwerf S, Mesman E, Schellens JH, Begg AC, van Blitterswijk WJ, Verheij M.
    Clin Cancer Res; 2006 Mar 01; 12(5):1615-22. PubMed ID: 16533789
    [Abstract] [Full Text] [Related]

  • 10. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.
    Nielsen LL, Lipari P, Dell J, Gurnani M, Hajian G.
    Clin Cancer Res; 1998 Apr 01; 4(4):835-46. PubMed ID: 9563876
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. All-trans-retinoic acid enhances the effect of adenovirus-mediated wild-type p53 gene transfer in head and neck squamous cell carcinoma.
    Nakashima T, Sun SY, Lotan R, Fujiwara T, Yasumatsu R, Komiyama S, Clayman GL.
    Laryngoscope; 2001 Aug 01; 111(8):1459-64. PubMed ID: 11568584
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
    Pederson LC, Buchsbaum DJ, Vickers SM, Kancharla SR, Mayo MS, Curiel DT, Stackhouse MA.
    Cancer Res; 1997 Oct 01; 57(19):4325-32. PubMed ID: 9331094
    [Abstract] [Full Text] [Related]

  • 16. Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications.
    Horowitz J.
    Curr Opin Mol Ther; 1999 Aug 01; 1(4):500-9. PubMed ID: 11713766
    [Abstract] [Full Text] [Related]

  • 17. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression.
    Ji L, Fang B, Yen N, Fong K, Minna JD, Roth JA.
    Cancer Res; 1999 Jul 15; 59(14):3333-9. PubMed ID: 10416589
    [Abstract] [Full Text] [Related]

  • 18. Radiosensitization of head/neck squamous cell carcinoma by adenovirus-mediated expression of the Nbs1 protein.
    Rhee JG, Li D, Suntharalingam M, Guo C, O'Malley BW, Carney JP.
    Int J Radiat Oncol Biol Phys; 2007 Jan 01; 67(1):273-8. PubMed ID: 17189075
    [Abstract] [Full Text] [Related]

  • 19. Head and neck squamous cell growth suppression using adenovirus-p53-FLAG: a potential marker for gene therapy trials.
    Overholt SM, Liu TJ, Taylor DL, Wang M, El-Naggar AK, Shillitoe E, Adler-Storthz K, John LS, Zhang WW, Roth JA, Clayman GL.
    Clin Cancer Res; 1997 Feb 01; 3(2):185-91. PubMed ID: 9815671
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.